Letter: mesalazine-a safe drug with rare serious adverse events? Authors' reply
ALIMENTARY PHARMACOLOGY & THERAPEUTICS（2020）
摘要
LINKED CONTENT This article is linked to Sehgal et al and Scrivo et al papers. To view these articles, visit and .
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要